Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Universal Century Technology is a specialized medical technology company based in China that focuses on the research, development, and manufacturing of in vitro diagnostic (IVD) instruments and reagents. The company is a leader in the field of magnetic particle chemiluminescence immunoassay (CLIA) technology, offering a range of automated systems like the UC6000 and UC1000 series. Their diagnostic menu includes a comprehensive suite of assays for tumor markers, cardiac biomarkers, inflammatory markers, and hormones. By integrating advanced hardware with proprietary reagent formulations, the company provides high-sensitivity and high-throughput solutions for clinical laboratories and hospitals. Beijing Universal Century Technology is committed to enhancing diagnostic accuracy and efficiency in the global healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Universal Century Technology.